In this installment of Clinical Trial Corner, Dr. Dina Khalaf, a clinical associate professor in the University of Florida ...
Patients with early-stage EGFR-mutated non-small cell lung cancer (NSCLC) who took Tagrisso (osimertinib) for three years ...
WCLC 2026 brought new lung cancer data on HER2-mutant, PD-L1-positive and EGFR exon 20 insertion-positive non-small cell lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results